INSM Insmed - tpip demonstrates sustained improvement and reduced mortality risk at 12 months - Tpip safe and well-tolerated with no new saf

INSM Insmed - tpip demonstrates sustained improvement and reduced mortality risk at 12 months - Tpip safe and well-tolerated with no new safety signals through month 12